Mitch C. Hill - 16 Feb 2024 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Financial Officer
Signature: /s/ Shannon Trevino, attorney-in-fact for Mitch C. Hill
Issuer symbol: N/A
Transactions as of: 16 Feb 2024
Net transactions value: +$948,540
Form type: 4
Filing time: 21 Feb 2024, 21:55:13 UTC
Previous filing: 03 Jan 2024
Next filing: 14 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Award	$0	+14,812	+8.8%	$0.000000	183,361	16 Feb 2024	Direct	F1, F2
holding	NARI	Common Stock						1,600	16 Feb 2024	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Options (Right to Buy)	Award	$948,540	+16,231		$58.44	16,231	16 Feb 2024	Common Stock	16,231	$58.44	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents annual restricted stock units ("RSUs") awarded to the reporting person, with a vesting commencement date of January 1, 2024 (the "Vesting Commencement Date"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
F2	Includes 61 shares acquired on January 31, 2024 under the Employee Stock Purchase Plan.
F3	Represents options to purchase shares of Issuer common stock which were granted on February 16, 2024 under the Issuer's 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis, with the first tranche vesting on April 1, 2024.